Kestra Medical Technologies, Ltd. Preferred Stock Dividends, Income Statement Impact
Kestra Medical Technologies, Ltd. (KMTS) reported Preferred Stock Dividends, Income Statement Impact of $12.32 million for the 12-month period ending 2025-04-30, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2026-07-14
- Kestra Medical Technologies, Ltd. preferred stock dividends, income statement impact for the quarter ending 2025-04-30 was $3.29M.
- Kestra Medical Technologies, Ltd. preferred stock dividends, income statement impact for the quarter ending 2025-01-31 was $3.32M.
- Kestra Medical Technologies, Ltd. preferred stock dividends, income statement impact for the quarter ending 2024-10-31 was $3.32M.
- Kestra Medical Technologies, Ltd. preferred stock dividends, income statement impact for the quarter ending 2024-07-31 was $2.38M.
- Kestra Medical Technologies, Ltd. preferred stock dividends, income statement impact for fiscal 2025 was $12.32M, a 83.32% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. preferred stock dividends, income statement impact for fiscal 2024 was $6.72M.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|
| 2025-04-30 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $6.62M derived: sum of 2 quarters · filed 2026-07-14 | $9.94M derived: sum of 3 quarters · filed 2026-07-14 | $12.32M 10-K · filed 2026-07-14 |
| 2025-01-31 | $3.32M 10-Q · filed 2026-03-17 | $6.65M derived: sum of 2 quarters · filed 2026-03-17 | $9.03M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $3.32M 10-Q · filed 2025-12-11 | $5.71M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $2.38M 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $6.72M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |